This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.

Learning Objectives

At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

Hematology

Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors

Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies

Understand blood and marrow morphology and hematopathology

Understand red cell disorders

Hematologic Malignancies

Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs

Be familiar with the diagnosis, evaluation, and management of hematologic malignancies

Identify strategies for taking the board examinations

Oncology

Understand the epidemiology of malignant diseases and management of the medical complications of malignancy

Comprehend the principles of management of gynecologic and other genito-urinary malignancies

Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract

Recognize principles of new developments in biologic therapy of cancer

COURSE CONTENT

Hematology Sessions:

Session 0 (Hematology): Anemias, Porpyrias, Red Cell Enzymes, Clotting, Cellular Morphology and Liquid Biopsies (4.00 hours)

Session 1: Iron Deficiency, Hemoglobinopathies, Hemolytic Anemia, Hemophilias, Transfusion Medicine, Hematologic Complications of Pregnancy and Platelet Alloimmunization (9.00 hours)

Session 2: Sickling Disorders, Consumptive Thrombohemorrhagic Disorders, Bone Marrow Failure, White Cell Disorders, DIC, HIT, VITT, Ischemic Limb Gangrene, ABO Incompatibility, ITP Drug-Induced Thrombocytopenia and Hematopoietic Transplantation (8.75 hours)

Hematologic Malignancies Sessions:

Session 3: Lymphomas, Multiple Myeloma, MGUS, ALL, CML, Plasma Cell Disorders, Myelodysplasia, Waldenstrom’s Macroglobulinemia and Palliative Care (9.25 hours)

Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms, CLL, Pharmacology and T Cell Therapies (9.25 hours)

Medical Oncology Sessions:

Session 5: Head/Neck Cancer, Familial Cancer Syndromes, Lung Cancer, Breast Cancer, Lung Cancer, Neuro-Oncology and Endocrine Malignancies (9.00 hours)

Session 6: Renal Cell, Prostate, Bladder, Testicular, Ovarian, Endometrial Tumors, Melanoma, Carcinoid Tumors and Mesothelioma (10.00 hours)

Session 7: GI Oncology, Pancreatic Cancer and Sarcomas (6.75 hours)